Cargando…

Aquaporin-4 positive neuromyelitis optica spectrum disorders secondary to thrombopenic purpura: A case report

RATIONALE: Neuromyelitis optica spectrum disorders (NMOSD) is considered as an immune-mediated disorder in the central nervous system (CNS). Numerous autoimmune diseases are frequently complicated with NMOSD and distinct clinical characteristics are noted in NMOSD patients with other autoimmune dise...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ying, Gong, Qiaoyun, Zhu, Mingqin, Lu, Chao, Sun, Li, Feng, Jiachun, Zhang, Hongliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5266166/
https://www.ncbi.nlm.nih.gov/pubmed/28079804
http://dx.doi.org/10.1097/MD.0000000000005792
_version_ 1782500419526721536
author Wang, Ying
Gong, Qiaoyun
Zhu, Mingqin
Lu, Chao
Sun, Li
Feng, Jiachun
Zhang, Hongliang
author_facet Wang, Ying
Gong, Qiaoyun
Zhu, Mingqin
Lu, Chao
Sun, Li
Feng, Jiachun
Zhang, Hongliang
author_sort Wang, Ying
collection PubMed
description RATIONALE: Neuromyelitis optica spectrum disorders (NMOSD) is considered as an immune-mediated disorder in the central nervous system (CNS). Numerous autoimmune diseases are frequently complicated with NMOSD and distinct clinical characteristics are noted in NMOSD patients with other autoimmune diseases. However, to our best knowledge, co-occurrence of NMOSD and thrombopenic purpura is rarely identified. PATIENT CONCERNS: We presented a rare case of a 72-year-old female with 6-year history of thrombopenic purpura, and 1-month history of blurred vision as well as chest zonethesia. Anti-aquaporin-4 (AQP4) antibodies was positive in the serum of the patient. DIAGNOSES: With the addition of laboratory findings, iconography findings and physical examination results, the diagnosis of NMOSD was established according to the most recent diagnostic criteria. INTERVENTIONS AND OUTCOMES: With the treatment of intravenous immunoglobulin (IVIg), the patient felt better at discharge without changing of expanded disability status scale (EDSS) score. LESSONS: The case indicates that NMOSD could co-occur with thrombopenic purpura. The disturbance of immune system balance may explain this overlap. Further studies are warranted to reveal the mechanism and to explore whether patients with NMOSD with and without thrombopenic purpura have distinct clinical feature, drug responsiveness or prognosis.
format Online
Article
Text
id pubmed-5266166
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-52661662017-02-07 Aquaporin-4 positive neuromyelitis optica spectrum disorders secondary to thrombopenic purpura: A case report Wang, Ying Gong, Qiaoyun Zhu, Mingqin Lu, Chao Sun, Li Feng, Jiachun Zhang, Hongliang Medicine (Baltimore) 5300 RATIONALE: Neuromyelitis optica spectrum disorders (NMOSD) is considered as an immune-mediated disorder in the central nervous system (CNS). Numerous autoimmune diseases are frequently complicated with NMOSD and distinct clinical characteristics are noted in NMOSD patients with other autoimmune diseases. However, to our best knowledge, co-occurrence of NMOSD and thrombopenic purpura is rarely identified. PATIENT CONCERNS: We presented a rare case of a 72-year-old female with 6-year history of thrombopenic purpura, and 1-month history of blurred vision as well as chest zonethesia. Anti-aquaporin-4 (AQP4) antibodies was positive in the serum of the patient. DIAGNOSES: With the addition of laboratory findings, iconography findings and physical examination results, the diagnosis of NMOSD was established according to the most recent diagnostic criteria. INTERVENTIONS AND OUTCOMES: With the treatment of intravenous immunoglobulin (IVIg), the patient felt better at discharge without changing of expanded disability status scale (EDSS) score. LESSONS: The case indicates that NMOSD could co-occur with thrombopenic purpura. The disturbance of immune system balance may explain this overlap. Further studies are warranted to reveal the mechanism and to explore whether patients with NMOSD with and without thrombopenic purpura have distinct clinical feature, drug responsiveness or prognosis. Wolters Kluwer Health 2017-01-13 /pmc/articles/PMC5266166/ /pubmed/28079804 http://dx.doi.org/10.1097/MD.0000000000005792 Text en Copyright © 2017 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0
spellingShingle 5300
Wang, Ying
Gong, Qiaoyun
Zhu, Mingqin
Lu, Chao
Sun, Li
Feng, Jiachun
Zhang, Hongliang
Aquaporin-4 positive neuromyelitis optica spectrum disorders secondary to thrombopenic purpura: A case report
title Aquaporin-4 positive neuromyelitis optica spectrum disorders secondary to thrombopenic purpura: A case report
title_full Aquaporin-4 positive neuromyelitis optica spectrum disorders secondary to thrombopenic purpura: A case report
title_fullStr Aquaporin-4 positive neuromyelitis optica spectrum disorders secondary to thrombopenic purpura: A case report
title_full_unstemmed Aquaporin-4 positive neuromyelitis optica spectrum disorders secondary to thrombopenic purpura: A case report
title_short Aquaporin-4 positive neuromyelitis optica spectrum disorders secondary to thrombopenic purpura: A case report
title_sort aquaporin-4 positive neuromyelitis optica spectrum disorders secondary to thrombopenic purpura: a case report
topic 5300
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5266166/
https://www.ncbi.nlm.nih.gov/pubmed/28079804
http://dx.doi.org/10.1097/MD.0000000000005792
work_keys_str_mv AT wangying aquaporin4positiveneuromyelitisopticaspectrumdisorderssecondarytothrombopenicpurpuraacasereport
AT gongqiaoyun aquaporin4positiveneuromyelitisopticaspectrumdisorderssecondarytothrombopenicpurpuraacasereport
AT zhumingqin aquaporin4positiveneuromyelitisopticaspectrumdisorderssecondarytothrombopenicpurpuraacasereport
AT luchao aquaporin4positiveneuromyelitisopticaspectrumdisorderssecondarytothrombopenicpurpuraacasereport
AT sunli aquaporin4positiveneuromyelitisopticaspectrumdisorderssecondarytothrombopenicpurpuraacasereport
AT fengjiachun aquaporin4positiveneuromyelitisopticaspectrumdisorderssecondarytothrombopenicpurpuraacasereport
AT zhanghongliang aquaporin4positiveneuromyelitisopticaspectrumdisorderssecondarytothrombopenicpurpuraacasereport